{"database": "lobbying", "table": "lobbying_activities", "rows": [[2261848, "597081be-a5cb-4d15-9286-5b161fa56365", "Q1", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2019, "first_quarter", "MMM", "HHS rules and regulations related  to the cost of prescription drugs, including, but not limited to,  limiting rebates in the Medicare and Medicaid prescription drug benefits.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2019-04-04T15:25:32.360000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2261848"], "units": {}, "query_ms": 0.5173810059204698, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}